Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.01.052Source: DataRank Database

Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 2.19)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Felix M. Chinea ORCID,Elizabeth Bossart ORCID,Deukwoo Kwon ORCID,Matthew C. Abramowitz ORCID,Charles M. Lynne

Live enrichment

PubMed:32084522 PMC:PMC7424349 OpenAlex:https://openalex.org/W3007837519

National Institutes of Health

Grant: R21CA153826

NCI NIH HHS

Grant: P30 CA240139

National Institutes of Health

Grant: 5R21CA153826-02

MRI-Guided Radiotherapy and Biomarkers for Prostate Cancer

National Cancer Institute

FWCI

2.19

Citation Percentile

0.9%

Citation Trend

2017

2020

2021

2022

2023

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7424349

publisherhttps://api.elsevier.com/content/article/PII:S0360301620302182?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0360301620302182?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ijrobp.2020.01.052

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32084522

Fields of Study

Prostate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research03 medical and health sciences0302 clinical medicine

MeSH Terms

AdultAgedAged, 80 and overFeasibility StudiesHumansMagnetic Resonance ImagingMaleMiddle AgedProstatic NeoplasmsSafetySeminal VesiclesTomography, X-Ray ComputedAblation TechniquesRadiotherapy, Image-Guided

Keywords

MedicineProstate cancerGenitourinary systemProstateAblative caseNuclear medicineRadiation therapyUrologyRadiologyCancerInternal medicineAblation TechniquesAdultAged, 80 and overMaleProstatic NeoplasmsSeminal VesiclesMiddle AgedMagnetic Resonance ImagingFeasibility StudiesHumansSafetyTomography, X-Ray ComputedAgedRadiotherapy, Image-Guided

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Phase I Trial of MRI-Guided Prostate Cancer Lattice Extreme Ablative Dose (LEAD) Boost Radiation Therapy

FAIR Checklist

Authors (14)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)